Panjang
TomoChain (TOMOUSDT) Bullish Now, Next Target

TomoChain (TOMOUSDT) is now bullish vs TeTherUS (USDT).
Here we have a strong break above all moving averages, EMA10/50/200 and MA200, this is a strong bullish signal.
We also have very high volume with the MACD and RSI allowing for additional growth.
The next targets are marked with magenta dashed lines on the chart.
The yellow marked area is for support.
Above this level, and MA200 (0.4167), TOMOUSDT remains strongly bullish.
Below this level we go bearish.
Remember to hit LIKE for more.
Namaste.
Here we have a strong break above all moving averages, EMA10/50/200 and MA200, this is a strong bullish signal.
We also have very high volume with the MACD and RSI allowing for additional growth.
The next targets are marked with magenta dashed lines on the chart.
The yellow marked area is for support.
Above this level, and MA200 (0.4167), TOMOUSDT remains strongly bullish.
Below this level we go bearish.
Remember to hit LIKE for more.
Namaste.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.